Search - tctmd.com

Displaying 261 - 280 of 451

Sort: Relevancy | Date

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia

L.A. McKeown

June 13, 2018

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

L.A. McKeown

May 16, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Daily News

Value of Ambulatory BP Monitoring Bolstered by Large Study

Todd Neale

April 18, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Daily News

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

L.A. McKeown

March 29, 2018

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

News Daily News

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

Michael O'Riordan

February 14, 2018

Advertisement

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia

New European Hypertension Guidelines Not in Harmony With US Guidance

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Value of Ambulatory BP Monitoring Bolstered by Large Study

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content